View price in:  
Sinemet CR (Carbidopa/Levodopa)
click to see larger image

Sinemet CR (Carbidopa/Levodopa)

Controlled release version of Sinemet
Used to treat Parkinson's disease
Enhances dopamine levels
Size:
Our Price:
USD57.99
Free Delivery
EU Licensed Pharmacy
Sinemet CR (Carbidopa/Levodopa)
click to see larger image

Sinemet CR (Carbidopa/Levodopa)

Product Reviews

Write an online review and share your thoughts.

WHAT


Sinemet CR is the controlled release version of Sinemet. Sinemet was developed by German pharmaceutical firm Merck and comprises two medications in one product - carbidopa and levodopa. It works by increasing dopamine levels which in turn helps to improve symptoms associated with the neurological disorder Parkinson's disease.

WHY


Sinemet is listed on the World Health Organisation's list of essential medicines, rated as being both highly effective and very safe. With a long history of use, Sinemet is one of the medicines most favoured by physicians for managing Parkinson's sypmtoms. Sinemet is taken orally and can show benefits in a matter of as little as one week.

WHO


Sinemet is licensed for use in treating adults suffering from Parkinson's disease.

WHEN


Sinemet CR allows the dosing to be less frequent however dosing should be based on the supervising clinician's view.

Patient Leaflet


Controlled release version of Sinemet
Used to treat Parkinson's disease
Enhances dopamine levels